Structures by: Mnguni M. J.
Total: 8
Theophylline--3,4-dihydroxybenzoic acid (1/1)
C7H8N4O2,C7H6O4
Acta Crystallographica Section C (2018) 74, 6
a=6.7095(3)Å b=13.7764(6)Å c=30.7205(15)Å
α=90° β=90° γ=90°
4-Amino-1,5-dimethyl-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-3-one
C11H13N3O
Acta Crystallographica Section C (2015) 71, 2
a=7.45190(10)Å b=7.45190(10)Å c=31.8705(7)Å
α=90° β=90° γ=120°
(<i>Z</i>)-Methyl 3-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)amino]but-2-enoate
C16H19N3O3
Acta Crystallographica Section C (2015) 71, 2
a=11.2061(14)Å b=7.4638(8)Å c=19.044(2)Å
α=90° β=106.655(4)° γ=90°
Ethyl 2-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)amino]cyclohex-1-enecarboxylate
C20H25N3O3
Acta Crystallographica Section C (2015) 71, 2
a=7.3857(2)Å b=9.2159(3)Å c=13.7494(4)Å
α=85.8980(10)° β=84.4990(10)° γ=85.2100(10)°
(<i>Z</i>)-Ethyl 3-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)amino]but-2-enoate
C17H21N3O3
Acta Crystallographica Section C (2015) 71, 2
a=13.427(2)Å b=10.1086(14)Å c=12.2801(18)Å
α=90° β=101.690(5)° γ=90°
(<i>Z</i>)-Ethyl 3-[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)amino]-3-phenylacrylate
C22H23N3O3
Acta Crystallographica Section C (2015) 71, 2
a=8.4851(7)Å b=12.4253(10)Å c=18.0314(18)Å
α=90° β=92.282(3)° γ=90°
2-Cyano-<i>N</i>-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)acetamide
C14H14N4O2
Acta Crystallographica Section C (2015) 71, 2
a=6.9996(8)Å b=12.3350(16)Å c=15.8345(19)Å
α=90° β=99.666(4)° γ=90°
Methyl 4-{[(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1<i>H</i>-pyrazol-4-yl)amino]methyl}benzoate
C20H19N3O3
Acta Crystallographica Section C (2015) 71, 2
a=32.7563(10)Å b=6.9258(2)Å c=16.4002(5)Å
α=90° β=106.0320(10)° γ=90°